Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
News
InfiCure Bio attends AFDD November 16-18
Sofia Mayans and Dan Holmberg will attend the Annual AFDD meeting, this year an entirely digital event: https://afdd-summit.com/
Autumn is here and the future is bright!
The annual retreat for InfiCure Bio took place last week and we had fruitful and interesting discussions on future progress of the company. Validation of the NIF mouse as a spontaneous liver model is complete [...]
Thesis defense
Julia Nilsson will defend her thesis "Cellular and molecular mechanisms in immune mediated hepatic fibrosis. A study of the inflammatory and fibrosis development of the NIF mouse liver" on Friday May 15th at 9.15 CET. [...]
Welcome Kajsa Linde!
InfiCure Bio is happy to announce that Kajsa Linde has joined our team as a Senior Scientist. Prior to her position at InfiCure Bio she was working at Betagenon as a Research Engineer. We are [...]